The high school students at the McKenzie Center for Innovation and Technology in Indianapolis will be participating in the International Genetically Engineered Machine (iGEM) competition this year thanks to the generous sponsorship of Rimedion. Based in Indianapolis, Rimedion is a gene therapy company working on unique gene therapies and associated technologies for advancing the field. The company was founded by Dr. Ken Cornetta, Chair of Medical and Molecular Genetics for the IU School of Medicine and Director of the NIH Gene Vector Bio Repository and the IU Vector Production Facility.
The students, who participate in the Project Lead the Way curriculum, will be working with their instructor to develop a bio-reactive gel to help identify skin cancer. Other Indiana teams will also be participating in the competition and we wish them all the best of luck! IHIF is also helping to sponsor the McKenzie team and will be reporting on the students’ projects in the upcoming 2013 edition of BioFutures, available in March.